Cargando…

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery

Detalles Bibliográficos
Autores principales:	Rudrapal, Mithun, Paudel, Keshav Raj, Pangeni, Rudra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808379/ https://www.ncbi.nlm.nih.gov/pubmed/36605397 http://dx.doi.org/10.3389/fphar.2022.1101007

Ejemplares similares

Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
por: Pinzi, Luca, et al.
Publicado: (2021)

Target-specific compound selectivity for multi-target drug discovery and repurposing
por: Wang, Tianduanyi, et al.
Publicado: (2022)

Applying polypharmacology approach for drug repurposing for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2022)

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
por: Chu, Ming, et al.
Publicado: (2018)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Computational polypharmacology comes of age
por: Rastelli, Giulio, et al.
Publicado: (2015)

Chemogenomics knowledgebased polypharmacology analyses of drug abuse related G-protein coupled receptors and their ligands
por: Xie, Xiang-Qun, et al.
Publicado: (2014)

Evolution of kinase polypharmacology across HSP90 drug discovery
por: Antolin, Albert A., et al.
Publicado: (2021)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

A Comparative Study of Cluster Detection Algorithms in Protein–Protein Interaction for Drug Target Discovery and Drug Repurposing
por: Ma, Jun, et al.
Publicado: (2019)

Editorial: Translational Research and Drug Repurposing for Non-Communicable Diseases (NCDs)
por: Akindele, Abidemi J., et al.
Publicado: (2022)

Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets
por: Saqib, Uzma, et al.
Publicado: (2018)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies
por: Nikolic, Katarina, et al.
Publicado: (2016)

Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
por: Liu, Tsang-Pai, et al.
Publicado: (2018)

Polypharmacology: promises and new drugs in 2022
por: Ryszkiewicz, Piotr, et al.
Publicado: (2023)

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
por: Saha, Rudra P., et al.
Publicado: (2020)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

Editorial: Pharmacology of Plant Polyphenols in Human Health and Diseases
por: Devkota, Hari Prasad, et al.
Publicado: (2022)

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
por: Kalra, Rajkumar Singh, et al.
Publicado: (2022)

Editorial: Targeted drug discovery in ectopic calcification: mechanism, prospect, and clinical application
por: Xu, Kang, et al.
Publicado: (2023)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

An Integrative Heterogeneous Graph Neural Network–Based Method for Multi-Labeled Drug Repurposing
por: Sadeghi, Shaghayegh, et al.
Publicado: (2022)

Editorial: Methods and application in experimental pharmacology and drug discovery: 2021
por: Polito, Letizia, et al.
Publicado: (2022)

Editorial: Metabolomics as a tool in ethnobotany-driven drug discoveries
por: Makunga, Nokwanda, et al.
Publicado: (2022)

Editorial: Model organisms in experimental pharmacology and drug discovery 2022
por: Nainu, Firzan, et al.
Publicado: (2023)

Editorial: Spotlight on artificial intelligence in experimental pharmacology and drug discovery
por: Schöning, Verena, et al.
Publicado: (2023)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

Screening of GPCR drugs for repurposing in breast cancer
por: Abdulkareem, Noor Mazin, et al.
Publicado: (2022)

Polypharmacology guided drug repositioning approach for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2023)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Drug-target and disease networks: polypharmacology in the post-genomic era
por: Masoudi-Nejad, Ali, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ou0u4pe1bacjeog2o6t44sd9pr